Brain photobiomodulation therapy: a narrative review
Brain photobiomodulation (PBM) therapy using red to near-infrared (NIR) light is an
innovative treatment for a wide range of neurological and psychological conditions. Red/NIR …
innovative treatment for a wide range of neurological and psychological conditions. Red/NIR …
Brain photobiomodulation therapy on neurological and psychological diseases
H Chamkouri, Q Liu, Y Zhang, C Chen… - Journal of …, 2024 - Wiley Online Library
Photobiomodulation (PBM) therapy is an innovative treatment for neurological and
psychological conditions. Complex IV of the mitochondrial respiratory chain can be …
psychological conditions. Complex IV of the mitochondrial respiratory chain can be …
Lower cerebral perfusion is associated with tau-PET in the entorhinal cortex across the Alzheimer's continuum
Alzheimer's disease (AD) is associated with reduced temporo-parietal cerebral blood flow
(CBF). However, a substantial variability in CBF across the clinical spectrum of AD has been …
(CBF). However, a substantial variability in CBF across the clinical spectrum of AD has been …
In Alzheimer's disease, amyloid beta accumulation is a protective mechanism that ultimately fails
Hypothesis and predictions Here, we claim that amyloid beta (Aβ) accumulation is a
protective mechanism that ultimately fails. We predict that more Aβ accumulates in regions …
protective mechanism that ultimately fails. We predict that more Aβ accumulates in regions …
[HTML][HTML] Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study
EE Wolters, M Van de Beek, R Ossenkoppele… - NeuroImage: Clinical, 2020 - Elsevier
Purpose Alpha-synuclein often co-occurs with Alzheimer's disease (AD) pathology in
Dementia with Lewy Bodies (DLB). From a dynamic [18 F] flortaucipir PET scan we derived …
Dementia with Lewy Bodies (DLB). From a dynamic [18 F] flortaucipir PET scan we derived …
A new integrated dual time-point amyloid PET/MRI data analysis method
Purpose In the initial evaluation of patients with suspected dementia and Alzheimer's
disease, there is no consensus on how to perform semiquantification of amyloid in such a …
disease, there is no consensus on how to perform semiquantification of amyloid in such a …
Frailty, MRI, and FDG-PET measures in an Australian memory clinic cohort
N Jordan, M Gvalda, R Cody, O Galante… - Frontiers in …, 2021 - frontiersin.org
Given that the global population is aging, the number of age-related syndromes, such as
frailty, is expected to rise in conjunction. Frailty is characterized by the loss of homeostatic …
frailty, is expected to rise in conjunction. Frailty is characterized by the loss of homeostatic …
Circular inference in dementia diagnostics
PF Høilund-Carlsen, JR Barrio… - Journal of …, 2018 - content.iospress.com
Referring to recent international articles stating that amyloid imaging or detection has a high
additive value in making a diagnosis of Alzheimer's disease (AD) when previous …
additive value in making a diagnosis of Alzheimer's disease (AD) when previous …
Photobiomodulation Therapy on Brain: Pioneering an Innovative Approach to Revolutionize Cognitive Dynamics
Photobiomodulation (PBM) therapy on the brain employs red to near-infrared (NIR) light to
treat various neurological and psychological disorders. The mechanism involves the …
treat various neurological and psychological disorders. The mechanism involves the …
Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for …
CG Swinford, SL Risacher, A Vosmeier, R Deardorff… - Neurobiology of …, 2023 - Elsevier
Identification of biomarkers for the early stages of Alzheimer's disease (AD) is an imperative
step in developing effective treatments. Cerebral blood flow (CBF) is a potential early …
step in developing effective treatments. Cerebral blood flow (CBF) is a potential early …